Answer
Breastfeeding should be discontinued during treatment with andexanet alfa because its excretion in human milk is unknown and a risk to newborns or infants cannot be excluded.
Sources for this answer
- Ondexxya 200 mg powder for solution for infusionAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 17Document updated
Sources checked